Gene therapy successes point to better therapies
Elie Dolgin • Nov 26, 2019
Despite some data concerns, two treatments for a rare pediatric killer could usher in a new wave of innovative medicines for neurological conditions.
Continue reading at PNAS.
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
FDA panel’s green light on glaucoma wearable device offers hope in sight.